0001971101-23-000002.txt : 20230403 0001971101-23-000002.hdr.sgml : 20230403 20230403102534 ACCESSION NUMBER: 0001971101-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 EFFECTIVENESS DATE: 20230403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Encentrio Therapeutics, Inc. CENTRAL INDEX KEY: 0001971101 IRS NUMBER: 921859581 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-477694 FILM NUMBER: 23791156 BUSINESS ADDRESS: STREET 1: 1800 OWENS ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 41 79 934 94 49 MAIL ADDRESS: STREET 1: 1800 OWENS ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001971101 Encentrio Therapeutics, Inc. 1800 OWENS ST. SAN FRANCISCO CA CALIFORNIA 94158 41 79 934 94 49 DELAWARE None None Corporation true 2023 Natascha Schill 1800 Owens Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Vanina de Verneuil 1800 Owens Street San Francisco CA CALIFORNIA 94158 Executive Officer Sung Lee 1800 Owens Street San Francisco CA CALIFORNIA 94158 Executive Officer Director George Scangos 1800 Owens Street San Francisco CA CALIFORNIA 94158 Director Johanna Friedl-Naderer 1800 Owens Street San Francisco CA CALIFORNIA 94158 Director Thomas Hecht 1800 Owens Street San Francisco CA CALIFORNIA 94158 Director Biotechnology Decline to Disclose 06b false 2023-03-20 false true false 0 400000 400000 0 false 1 0 0 0 false Encentrio Therapeutics, Inc. /s/ Natascha Schill Natascha Schill Chief Executive Officer 2023-04-03